SynthesisFrontiers in nutrition2025
The effects of cinnamon on patients with metabolic diseases: an umbrella review of meta-analyses of randomized controlled trials.
Synthesis in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Animal and clinical studies have demonstrated a range of potential health benefits associated with cinnamon. However, its effects on metabolic parameters such as blood glucose, blood pressure, lipid profiles, and body weight in patients with metabolic diseases remain controversial. To systematically assess the current evidence, we conducted an umbrella review of meta-analyses to comprehensively evaluate the impact of cinnamon supplementation on metabolic outcomes in patients with metabolic diseases. Methods: A systematic search was performed in PubMed, Embase, Web of Science, Scopus, and the Cochrane Library to identify relevant systematic reviews and meta-analyses of randomized placebo-controlled trials investigating cinnamon supplementation in individuals with metabolic diseases. The methodological quality and strength of evidence were assessed using AMSTAR 2 tool (A MeaSurement Tool to Assess systematic Reviews, version 2). Results: A total of 21 meta-analyses comprising 139 comparisons, were included for qualitative synthesis. The findings indicate that cinnamon supplementation is significantly associated with improvements in fasting blood glucose and lipid profiles, with more pronounced effects observed in patients with diabetes and metabolic syndrome. Subgroup analyses suggest that higher doses (>1.5 g/day) and shorter intervention durations (≤2 months) may enhance these benefits. Additionally, cinnamon shows potential in modulating insulin resistance, antioxidant capacity, and blood pressure regulation. Conclusion: These results underscore the promising role of cinnamon as an adjunctive therapy for metabolic diseases. Future research should focus on well-designed randomized controlled trials with extended follow-up periods to further confirm its efficacy and elucidate underlying mechanisms, thereby providing robust evidence for clinical and public health applications. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251010073, identifier: CRD420251010073.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.